Ziopharm Oncology (ZIOP) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q1 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Cash and cash equivalents, as of March 31, 2021 were $100.1 million.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
